期刊文献+

磷霉素与9种抗菌药物分别联用对不动杆菌的体外抗菌活性研究 被引量:9

In vitro antibacterial activity of fosfomycin combined with nine antimicrobial agents against acinetobacter
下载PDF
导出
摘要 [目的]研究磷霉素与其它9种临床常用抗菌药物分别联合应用对47株不动杆菌的体外抗菌活性。[方法]收集痰标本中分离出的不动杆菌47株,将磷霉素与其它9种抗菌药物在体外单独以及联合应用,采用琼脂二倍稀释法,测定最低抑菌浓度(M IC)、计算部分抑菌浓度(FIC)指数,评价磷霉素与其它9种抗菌药物分别联合应用的体外抗菌活性。[结果]磷霉素、左氧氟沙星、环丙沙星、头孢呋辛、头孢他啶、头孢吡肟、头孢哌酮/舒巴坦、阿米卡星单独应用时对47株不动杆菌的M IC50值均显示耐药,磷霉素分别与这9种抗菌药物在体外按1∶1联合应用后,M IC值均比单独应用时有所下降,FIC指数均≤2,协同及相加作用的比例大于无关作用的比例,未见拮抗作用,磷霉素与阿米卡星联用后,使后者由耐药变成敏感。[结论]磷霉素与左氧氟沙星、环丙沙星、头孢呋辛、头孢他啶、头孢吡肟、头孢哌酮/舒巴坦、美罗培南、亚胺培南/西司他丁、阿米卡星在体外分别联合应用对不动杆菌有协同及相加作用,增强了这9种抗菌药物的抗菌活性。 [Objective] To study the antibacterial activity of fosfomycin combined with other 9 antimicrobial agents against 47 strains of Acinetobacter in vitro,in order to provide laboratory data for clinical combination application.[Methods] The 47 strains of acinetobacter isolated from sputum samples were treated by 10 antimicrobial agents alone and by fosfomycin combined with other 9 antimicrobial agents.Through the minimal inhibitory concentration(MIC) and fractional inhibitory concentration(FIC) index,using a two-fold agar dilution method,we could evaluate the antibacterial activity of fosfomycin combined with other 9 antimicrobial agents in vitro.[Results] All the 47 strains of acinetobacter were resistant to fosfomycin,levofloxacin,ciprofloxacin,cefuroxime,ceftazidime,cefepime,cefoperazone/ sulbactam,amikacin,and were intermedium to meropenem and imipenem/cilastatin.The ratio of antimicrobial agents was 1∶ 1.The MICs of fosfomycin combined with other 9 antimicrobial agents were lower than those of 10 antimicrobial agents alone and FIC index≤2.The primary action was synergistic/additional effect.There was no antagonistic effect observed.[Conclusion] Synergistic/additional effect was observed in fosfomycin combined with levofloxacin,ciprofloxacin,cefuroxime,ceftazidime,cefepime,cefoperazone/sulbactam,amikacin,meropenem and imipenem/cilastatin against acinetobacter in vitro.The antimicrobial activities of combination were increased.
出处 《大连医科大学学报》 CAS 2011年第3期294-296,共3页 Journal of Dalian Medical University
关键词 磷霉素 不动杆菌 联合用药 体外抗菌活性 相互作用 fosfomycin acinetobacter antibiotics combination in vitro antibacterial activity interaction
  • 相关文献

参考文献6

二级参考文献18

  • 1胡志东,田彬,徐海茹,李琴,钟述猷.临床患者分离的鲍氏不动杆菌耐药性分析[J].中华医院感染学杂志,2005,15(1):112-114. 被引量:57
  • 2张樱,陈亚岗,杨青.不动杆菌感染及耐药机制的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(2):109-112. 被引量:93
  • 3国家药典委员会编.临床用药须知[M](第3版)[M].北京:化学工业出版社,2001.16-19.
  • 4Patel SS, Balfoud JA, Bryson HM. Fosfomycin trornethamine Areviewof its antibacterial activity, Pharmacokinetic ProPerties and therapeutic efficacy as a single-dose oral treatment-for acute uncomplicated lower urinary tract infections[J]. Drugs, 1997, 53(4) :637.
  • 5Forestier F, salvanet-Bouccara-A,Leveques-D, et al. Ocular Penetration Kinetics of fosfomycin administered as a one-hour infusion[J]. Eur J Ophthalmol, 1996, 6(2):137.
  • 6Scaglione F,cicchetti F, Demartini G, et al. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt[J]. Int J elin Pharmacol Res, 1994,14(3):107.
  • 7Legat FJ, Maier A, Dittrich P,et al. Penetration of fosfomycin into inflammatory Lesions in Patients with Cellulitis or diabetic foot syndrome[J]. Antimicrob Agents Chemother, 2003,47(1):371.
  • 8Kitamura K, Hirai H, Hosoya N,et al. Clinical efficacy of fosfomycin in combination with Sulbactam/cefoperazone in the treatment of Severe infections Complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBV/cpz[J]. Kansens hogaku Z,asshi, 1998, 72(7):761.
  • 9Morikawa K,OseKO F,Morikawa S. Immunomodulatory effect of fosfomycin on human B-lymphocyte function[J]. Antimicrob Agent s Chemother, 1993,37 (2) : 270.
  • 10Corti N,Sennha FH,Stauffer UG,et al. Fosfomycin for the initial treatment of acute haematogenous Osteomyelitis[J]. Arch Dis Child, 2003,88(6) : 512.

共引文献94

同被引文献98

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部